Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record page shows a 403 Forbidden message with a link back to Home, and the trial details are unavailable.
    Difference
    0.6%
    Check dated 2026-10-03T19:48:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record details, indicating restricted access rather than a content update.
    Difference
    18%
    Check dated 2026-09-19T18:36:54.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision label on the page updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a minor system update. The change does not modify study details, eligibility criteria, or other substantive content on the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:33:07.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision stamp updated from v3.6.4 to v3.6.5, signaling a routine platform update. The study page content and visible information appear unchanged.
    Difference
    0.1%
    Check dated 2026-08-08T09:46:30.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, indicating a minor page refresh rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-07-25T07:40:51.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    A new revision entry appears, updating the platform version to v3.6.3 and removing the previous v3.6.2 from the revision history.
    Difference
    0.1%
    Check dated 2026-07-03T22:45:01.000Z thumbnail image

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.